HIPAA Compliant
ISO 27001 CertifiedActively Recruiting
Led by University of Kansas Medical Center · Updated on 2025-12-11
80
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating a 12-week home-based mobile health mHealth intervention called the Shining Star study, aimed at improving adherence to the 24-Hour Movement Guidelines among preschool-aged children 3-4 years old who currently meet zero or one of the guidelines for physical activity, screen time, and sleep. The trial seeks to determine if the intervention increases the number of children meeting all three guidelines and if the program is feasible for parents to implement. This randomized controlled trial compares an intervention group using the app to a waitlist control group. Participants in the intervention group will use the Shining Star mobile app, which delivers weekly lessons and behavior-related goals through concise messages, gamification features, behavior trackers, and a parent forum. The control group will receive no intervention during the initial 12 weeks but will complete the same assessments as the intervention group. After 12 weeks, control group participants will gain access to the app and resources. Physical activity and sleep will be tracked with accelerometers, and parents will complete questionnaires. Childrens physical activity, sedentary behavior, and sleep patterns will be assessed at baseline, 6 weeks, and 12 weeks using accelerometers. Parents will provide feedback on their childs movement behaviors, development, and app usability through questionnaires and weekly surveys. Additional measures include motor skills tests, cognition assessments, behavioral problems, executive function, and BMI. Data will be securely stored and analyzed to evaluate the interventions impact and app feasibility over the 12-week period.
CONDITIONS
A Mobile App to Improve 24-Hour Movement Guideline Adherence in Preschoolers
D
Dr. Chelsea L Kracht, PhD
J
Jesse D Lyle, MHSA
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Kansas Medical Center
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Shining Star mHealth App | Wait‑list Control |
|---|---|---|
| What it is | A 12‑week home‑based mobile health (mHealth) intervention delivered via the Shining Star app, which gives parents weekly behavior‑related goals, educational lessons, gamified features, behavior trackers, child‑friendly content, reminders, and optional chat support to help their child meet the 24‑Hour Movement Guidelines. | A wait‑list control group in which parents and children do not receive the mobile app intervention during the 12‑week study period. |
| Purpose in the trial | To assess whether parent‑focused delivery of movement‑related goals and lessons via a mobile app can improve adherence to the 24‑Hour Movement Guidelines among preschoolers. | Serves as a comparison to assess feasibility and preliminary effectiveness of the app by observing outcomes when no intervention is provided. |
| How it is delivered | Parents use their own mobile phones over 12 weeks to receive brief messages (<500 characters), behavior goals, educational content, gamification elements, behavior trackers, child‑friendly features and optional chat support. | No app or intervention is delivered during the 12‑week study period; participants wait for access afterward. |
| Evidence status | Effectiveness is not yet established; trial is ongoing and aims to assess feasibility and preliminary impact on guideline adherence. | No evidence of effect as no intervention is provided; serves as baseline for comparison. |
| Important limitations | Results are pending and external generalizability may be limited; baseline digital access and parent engagement could affect feasibility. | As a non‑intervention arm, outcomes may reflect natural changes or measurement effects; it does not represent standard care outside the trial. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants in the intervention group use the Shining Star mobile app for 12 weeks, receiving weekly lessons and behavior-related goals to improve adherence to the 24-Hour Movement Guidelines. Parents engage with the app’s gamification features, behavior trackers, and forums. Assessments of physical activity, sleep, screen time, motor skills, cognition, behavioral problems, and executive function are conducted at baseline, Week 6, and Week 12.
3 visits (baseline, Week 6, and Week 12)
Duration - 12 weeks
Participants in the wait-list control group do not receive the intervention during the initial 12 weeks but complete the same assessments of physical activity, sleep, screen time, motor skills, cognition, behavioral problems, and executive function at baseline, Week 6, and Week 12. After this period, they gain access to the mobile app.
3 visits (baseline, Week 6, and Week 12)
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Chelsea L Kracht, Jerica M Berge, Monique LeBlanc...
https://pubmed.ncbi.nlm.nih.gov/41610419/University of Kansas Medical Center
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
